Answers are grounded in this paper and cite their sources.
Recent discoveries in the immunology and pathogenesis of HIV infection have fundamentally changed our understanding of primary HIV infection, and have the potential to revolutionize future HIV vaccine and therapeutic strategies. What was once thought of as a slow or even ‘latent’ viral infection, is now known to be an infection that rapidly infects and destroys the majority of memory CD4+CCR5+ T cells within days, or at least weeks, of primary infection, particularly those residing in mucosal effector sites. Unfortunately, these cells may be critical for generating or maintaining effective immune responses for both humoral and cell-mediated arms of the immune system, which could explain why the vast majority of HIV-infected patients develop AIDS, and our continuing difficulty in developing an effective vaccine. Recent advances in our understanding of acute HIV infection, the importance of the mucosal immune system in HIV pathogenesis, and the implications of these aspects in relation to vaccine approaches will be discussed in this review.
No takes yet. Share an insight, caveat, or question.
Ronald S. Veazey (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: